MUC5B: a good target for future therapy in pulmonary fibrosis?

[...]the small cohort sizes for the studies regarding systemic sclerosis and sarcoidosis made these analyses underpowered, and no replication cohort was assessed.

Saved in:
Bibliographic Details
Published inThorax Vol. 68; no. 5; p. 401
Main Authors Mahida, Rahul, Turner, Alice M
Format Journal Article
LanguageEnglish
Published England BMJ Publishing Group Ltd and British Thoracic Society 01.05.2013
BMJ Publishing Group LTD
Subjects
Female
Genetic Predisposition to Disease
Humans
Idiopathic Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis - genetics
Lung diseases
Male
Mortality
Mucin-5B - genetics
Patients
Polymorphism, Genetic
Pulmonary fibrosis
Pulmonary Fibrosis - genetics
Sarcoidosis
Scleroderma
Scleroderma, Systemic - complications
Studies
Systemic Disease and Lungs
Vital Capacity - genetics
Online AccessGet full text

Cover

More Information
Summary:[...]the small cohort sizes for the studies regarding systemic sclerosis and sarcoidosis made these analyses underpowered, and no replication cohort was assessed.
Bibliography:istex:4822BAE4EC41B07B7A631A6849D3F3C1B05B1E26
ark:/67375/NVC-LHND11KR-X
href:thoraxjnl-68-401.pdf
ArticleID:thoraxjnl-2012-202957
PMID:23329274
local:thoraxjnl;68/5/401
SourceType-Other Sources-1
content type line 63
ObjectType-Editorial-2
ObjectType-Commentary-1
ObjectType-Article-3
ISSN:0040-6376
1468-3296
DOI:10.1136/thoraxjnl-2012-202957